Komori
Mani (7730) · FactInterim results updatedLatest Earnings (2026-07-15): "Cited as achieved"

Trends in Revenue Growth and Profit Levels

First written in FY2016-Q3. 1 of 37 entries say "Cited as achieved", first in 2026-07-15. Latest entry: 2026-07-15.

37entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2016-Q3 – 2026-07-152016: 220162017: 420172018: 420182019: 420192020: 420202021: 420212022: 320222023: 420232024: 420242025: 220252026: 22026
Same theme, other companies
Performance trends diverging between revenue and order growth and changes in profitA theme 254 companies write about · 50 as a headwind · 74 as a tailwind

The whole theme swung hardest in 2020: 29 of 142 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 168 companies compared. The sentences above are computed from all 168.Comparing 200 of the theme's 292 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-07-15Cited as achievedEarnings

    「Net sales were ¥24,396 million, up 9.5% year on year. Gross profit increased to ¥16,281 million, up 14.3%, due to higher sales and an improvement in the cost-of-sales ratio resulting from the resumption of diamond bar sales.」

    For the cumulative third quarter, the company reported higher sales and an increase in gross profit.
  2. FY2026-H1Interim results updatedAnnual report

    「Net sales were ¥16,106 million, up 8.7% year on year. … Operating income rose sharply by 22.2% to ¥5,097 million. In addition to the increase in operating income, the recognition of foreign exchange gains due to the weaker yen led ordinary income to rise 31.4% to ¥5,619 million, while interim net income attributable to owners of the parent rose sharply by 32.6% to ¥3,898 million.」

    FY2026-H1 net sales were ¥16,106 million, operating income was ¥5,097 million, ordinary income was ¥5,619 million, and interim net income attributable to owners of the parent was ¥3,898 million, representing higher sales and profits year on year.
  3. FY2025Updated full-year resultsAnnual report

    「Net sales were ¥29,968 million, up 5.1% from the previous fiscal year. … Operating income declined 2.4% to ¥8,193 million. … Net income attributable to owners of the parent was ¥4,643 million, down 26.1%.」

    Although full-year net sales rose 5.1%, operating income fell 2.4% and net income for the year fell 26.1% due to higher selling, general and administrative expenses, Hanao Plant costs and MMG impairment, among other factors.
  4. FY2025-H1Interim results updatedAnnual report

    「Net sales rose 6.5% year on year to ¥14,810 million. Sales of surgical products such as ophthalmic knives remained strong in Europe, Asia, centered on China, and North America. Sales of products related to Ailes needles also increased in other regions such as Central and South America, mainly shipments to North American customers with production bases in Central and South America, as well as in Asia, centered on China. Dental products, however, remained weak due to the slowdown in the Chinese market and the impact of the voluntary suspension of shipments of diamond burs, as described below. Cost of sales rose 2.0% to ¥5,317 million due mainly to higher manufacturing costs at production subsidiaries, while gross profit increased 9.2% to ¥9,493 million. However, selling, general and administrative expenses rose 18.3% to ¥5,321 million, reflecting the recording of performance-based bonuses at headquarters related to the previous fiscal year's results and higher personnel expenses due to an increase in headcount. As a result, operating income declined slightly by 0.6% to ¥4,172 million. With the decrease in operating income and the reduction in foreign exchange gains, ordinary income fell 6.0% to ¥4,277 million, and interim net income attributable to owners of the parent fell 7.9% to ¥2,940 million, resulting in lower profit than in the same period of the previous year.」

    Although interim net sales rose 6.5% year on year, operating income, ordinary income and interim net income all fell below the same period of the previous year due to higher selling, general and administrative expenses and lower foreign exchange gains.
  5. FY2024Updated full-year resultsAnnual report

    「Net sales remained strong at ¥28,513 million, up 16.4% from the previous fiscal year. … Operating income was ¥8,392 million, up 15.8%. … Ordinary income was ¥8,464 million, up 5.9%, and net income attributable to owners of the parent was ¥6,286 million, up 5.6%.」

    The company disclosed full-year net sales of ¥28,513 million, operating income of ¥8,392 million, ordinary income of ¥8,464 million, and net income attributable to owners of the parent of ¥6,286 million, resulting in higher sales and profits.
  6. FY2024-Q3Updated third-quarter resultsAnnual report

    「Against a backdrop of increased sales mainly in Asia and North America, together with higher overseas sales due to the weaker yen, net sales remained strong at ¥21,610 million, up 16.7% year on year. … Operating income was ¥6,498 million, up 19.7%. With the increase in operating income and the recognition of foreign exchange gains, ordinary income rose 23.3% to ¥7,125 million, and net income attributable to owners of the parent rose 20.9% to ¥5,082 million, with the increase in profit widening from the same period of the previous year.」

    Cumulative FY2024-Q3 results were net sales of ¥21,610 million, operating income of ¥6,498 million, ordinary income of ¥7,125 million, and net income attributable to owners of the parent of ¥5,082 million, driven by increased sales in Asia and North America and the weaker yen.
  7. FY2024-Q2Updated second-quarter resultsAnnual report

    「Against a backdrop of increased sales mainly in Asia, North America and Europe, together with higher overseas sales due to the weaker yen, net sales remained strong at ¥13,908 million, up 15.7% year on year. On the other hand, cost of sales rose 7.6% to ¥5,213 million due mainly to higher manufacturing costs at overseas subsidiaries, while selling, general and administrative expenses rose 20.6% to ¥4,497 million due to higher promotional expenses accompanying strengthened marketing activities and higher personnel expenses at headquarters. However, driven by the expansion in net sales, operating income rose 21.5% to ¥4,197 million. With the increase in operating income and the recognition of foreign exchange gains, ordinary income rose 29.6% to ¥4,551 million, and net income attributable to owners of the parent rose 24.5% to ¥3,191 million, with the increase in profit widening from the same period of the previous year.」

    Cumulative FY2024-Q2 results showed higher sales and profits, driven by increased sales and the weaker yen: net sales were ¥13,908 million, operating income was ¥4,197 million, ordinary income was ¥4,551 million, and net income attributable to owners of the parent was ¥3,191 million.
  8. FY2024-Q1Updated first-quarter resultsAnnual report

    「Against a backdrop of increased sales mainly in Asia, North America, Japan and Europe, together with higher overseas sales due to the weaker yen, net sales remained strong at ¥7,114 million, up 16.5% year on year. … Operating income was ¥2,223 million, up 27.1%. With the substantial increase in operating income and the recognition of foreign exchange gains, ordinary income rose 35.4% to ¥2,349 million, and net income attributable to owners of the parent rose 21.1% to ¥1,573 million, with the increase in profit widening from the same period of the previous year.」

    FY2024-Q1 net sales were ¥7,114 million, operating income was ¥2,223 million, ordinary income was ¥2,349 million, and net income attributable to owners of the parent was ¥1,573 million, driven mainly by increased sales in Asia, North America, Japan and Europe, among other factors. The company disclosed higher sales and profits.
  9. FY2023Updated full-year resultsAnnual report

    「Net sales were ¥24,488 million, up 19.9% year on year. … Operating income was ¥7,243 million, up 17.5%. … Ordinary income was ¥7,995 million, up 6.0%, and net income attributable to owners of the parent was ¥5,953 million, up 12.5%, mainly due to higher operating income.」

    The company disclosed full-year net sales of ¥24,488 million, operating income of ¥7,243 million, ordinary income of ¥7,995 million, and net income attributable to owners of the parent of ¥5,953 million, resulting in higher sales and profits.
  10. FY2023-Q3Updated third-quarter resultsAnnual report

    「Compared with the same period of the previous year, which was affected by COVID-19, demand for products expanded mainly in Asia, Europe and South America, with demand for products related to Ailes needles increasing particularly sharply. In addition, higher overseas sales due to the weaker yen contributed, and net sales rose 24.9% to ¥18,521 million.」

    Cumulative FY2023-Q3 net sales were ¥18,521 million, up 24.9% year on year, driven by expanding demand and higher overseas sales due to the weaker yen. Operating income was ¥5,427 million, up 19.5%, ordinary income was ¥5,778 million, up 4.7%, and net income attributable to owners of the parent was ¥4,205 million, up 10.9%.
  11. FY2023-Q2Updated second-quarter resultsAnnual report

    「Compared with the same period of the previous year, which was affected by COVID-19, demand for products expanded mainly in Japan, Asia and Europe. Against a backdrop of particularly strong growth in demand for products related to Ailes needles, net sales rose 24.6% to ¥12,025 million.」

    For the six months ended, net sales were ¥12,025 million, up 24.6% year on year, operating income was ¥3,453 million, up 12.1%, ordinary income was ¥3,512 million, up 3.6%, and net income attributable to owners of the parent was ¥2,563 million, up 9.9%.
  12. FY2023-Q1Updated first-quarter resultsAnnual report

    「Compared with the same period of the previous year, which was affected by COVID-19, demand expanded in Japan, Europe and Asia, among other regions, and net sales rose 29.1% to ¥6,105 million. On the other hand, operating income rose 2.1% to ¥1,748 million, as higher manufacturing costs at overseas subsidiaries and higher cost of sales accompanying increased sales, together with higher selling, general and administrative expenses due to measures including strengthening the staffing structure, outweighed the increase in net sales. Although net sales and operating income increased, ordinary income fell 9.2% to ¥1,736 million, mainly because foreign exchange gains declined. Net income attributable to owners of the parent fell 1.8% to ¥1,299 million, mainly due to the decline in ordinary income and a decrease in deferred income taxes.」

    FY2023-Q1 net sales were ¥6,105 million, up 29.1% year on year, and operating income was ¥1,748 million, up 2.1%. On the other hand, ordinary income fell 9.2% to ¥1,736 million and net income attributable to owners of the parent fell 1.8% to ¥1,299 million, mainly due to the decline in foreign exchange gains.
  13. FY2022-Q3Updated third-quarter resultsAnnual report

    「Driven by expanded sales in Asia, a recovery in demand in Europe, and the foreign exchange impact of the weaker yen, net sales were ¥14,830 million, up 14.6% year on year. As in the second quarter, inventory disposal to review appropriate inventory levels worsened the cost of sales ratio, but operating income rose 6.4% to ¥4,543 million, mainly due to higher net sales. Ordinary income rose 19.5% to ¥5,521 million, mainly because foreign exchange gains increased from the same period of the previous year. Net income attributable to owners of the parent rose 8.9% to ¥3,790 million, despite the absence of the gain on sales of investment securities recorded in the same period of the previous year, mainly because ordinary income increased.」

    Cumulative FY2022-Q3 net sales rose 14.6%, operating income rose 6.4%, ordinary income rose 19.5%, and net income attributable to owners of the parent rose 8.9%.
  14. FY2022-Q2Updated second-quarter resultsAnnual report

    「Driven by expanded sales in Asia, centered on China, and a recovery in demand in Europe, net sales were ¥9,651 million, up 16.2% year on year. Although the disposal of inventory with no prospect of future shipment worsened the cost of sales ratio, operating income rose 15.6% to ¥3,079 million, mainly due to higher net sales. Ordinary income rose 23.7% to ¥3,390 million, mainly because foreign exchange gains increased from the same period of the previous year. Net income attributable to owners of the parent rose 15.8% to ¥2,333 million, despite the absence of the gain on sales of investment securities recorded in the same period of the previous year, mainly because ordinary income increased.」

    For the six months ended, the company disclosed net sales up 16.2%, operating income up 15.6%, ordinary income up 23.7%, and net income attributable to owners of the parent up 15.8%.
  15. FY2022-Q1Updated first-quarter resultsAnnual report

    「As demand recovered mainly in Europe and Asia, net sales were ¥4,728 million, up 12.6% year on year. Selling, general and administrative expenses increased due to stronger sales efforts by group companies and other factors, but operating income rose to ¥1,713 million, up 22.1%, due to higher net sales and an improved cost-of-sales ratio. Ordinary income was ¥1,911 million, up 50.3% due mainly to an increase in foreign exchange gains from the prior-year period, and quarterly net income attributable to owners of the parent was ¥1,322 million, up 34.4%, as the increase in ordinary income and other factors more than offset the absence of the gain on sales of investment securities recognized in the prior-year period.」

    FY2022-Q1 saw net sales increase 12.6%, operating income increase 22.1%, ordinary income increase 50.3% and quarterly net income attributable to owners of the parent increase 34.4%, against a backdrop of recovering demand in Europe and Asia.
  16. FY2021Updated full-year resultsAnnual report

    「Net sales for the fiscal year were ¥17,190 million, up 13.1% year on year, operating income was ¥5,348 million, up 23.2% due mainly to the increase in net sales, ordinary income was ¥5,679 million, up 28.4% due to an increase in foreign exchange gains from the prior-year period, and net income attributable to owners of the parent was ¥4,291 million, up 28.9%.」

    Full-year net sales increased 13.1%, operating income increased 23.2%, ordinary income increased 28.4% and net income attributable to owners of the parent increased 28.9%, marking a shift from declines in both revenue and profit in the previous fiscal year to increases in both.
  17. FY2021-Q3Updated third-quarter resultsAnnual report

    「As a result, net sales for the cumulative third quarter were ¥12,935 million, up 9.0% year on year, operating income was ¥4,268 million, up 15.8% due mainly to the increase in net sales, ordinary income was ¥4,621 million, up 21.7% due to an increase in foreign exchange gains, and quarterly net income attributable to owners of the parent was ¥3,480 million, up 22.1%.」

    FY2021-Q3 cumulative results showed increases in both revenue and profit, with net sales up 9.0%, operating income up 15.8%, ordinary income up 21.7% and quarterly net income attributable to owners of the parent up 22.1%.
  18. FY2021-Q2Updated second-quarter resultsAnnual report

    「As a result, net sales for the cumulative second quarter were ¥8,304 million, down 2.0% year on year, operating income was ¥2,665 million, down 4.2% due mainly to the decrease in net sales, ordinary income was ¥2,740 million, down 9.0%, and quarterly net income attributable to owners of the parent was ¥2,014 million, down 12.6% due mainly to a decrease in gains on sales of investment securities.」

    FY2021-Q2 net sales were ¥8,304 million, operating income was ¥2,665 million, ordinary income was ¥2,740 million and quarterly net income attributable to owners of the parent was ¥2,014 million, all down year on year.
  19. FY2021-Q1Updated first-quarter resultsAnnual report

    「As a result, net sales for the cumulative first quarter were ¥4,199 million, down 3.4% year on year, operating income was ¥1,403 million, up 0.1% due to a decrease in selling, general and administrative expenses, ordinary income was ¥1,271 million, down 19.5% despite the increase in operating income due mainly to a decrease in foreign exchange gains from the prior-year period, and quarterly net income attributable to owners of the parent was ¥984 million, down 6.3%, as the increase in gains on sales of investment securities and other factors partly offset the decline in ordinary income.」

    FY2021-Q1 saw a decline in revenue, while operating income edged up due to lower SG&A expenses. Ordinary income and quarterly net income attributable to owners of the parent declined due mainly to the decrease in foreign exchange gains.
  20. FY2020Updated full-year resultsAnnual report

    「Net sales for the fiscal year were ¥15,200 million, down 17.1% year on year, operating income was ¥4,340 million, down 26.0% due mainly to the decrease in net sales, ordinary income was ¥4,424 million, down 22.2% due to a decrease in foreign exchange losses from the prior-year period, and net income attributable to owners of the parent was ¥3,329 million, down 45.4% due to a decrease in gains on sales of investment securities from the sale of shares in line with the Corporate Governance Code’s policy of reducing cross-shareholdings.」

    Full-year net sales, operating income, ordinary income and net income all fell below the prior-year period.
  21. FY2020-Q3Updated third-quarter resultsAnnual report

    「As a result, net sales for the cumulative third quarter were ¥11,863 million, down 13.9% year on year, operating income was ¥3,685 million, down 18.1% due mainly to the decrease in net sales, ordinary income was ¥3,796 million, down 15.0% due to a decrease in foreign exchange losses from the prior-year period, and quarterly net income attributable to owners of the parent was ¥2,849 million, down 44.2% due to a decrease in gains on sales of investment securities recognized in the prior-year period.」

    Updated cumulative third-quarter net sales, operating income, ordinary income and quarterly net income attributable to owners of the parent, all of which declined year on year.
  22. FY2020-Q2Updated second-quarter resultsAnnual report

    「As a result, net sales for the cumulative second quarter were ¥8,475 million, down 6.7% year on year, while operating income was ¥2,782 million, down 4.3%, as an improved gross margin from discontinuing sales of dental operating microscopes and other products was offset by an increase in selling, general and administrative expenses. Ordinary income was ¥3,012 million, up 3.1% due to an increase in foreign exchange gains, and quarterly net income attributable to owners of the parent was ¥2,306 million, down 42.8% due to a decrease in gains on sales of investment securities from the prior-year period.」

    FY2020-Q2 net sales were ¥8,475 million, operating income was ¥2,782 million, ordinary income was ¥3,012 million and quarterly net income attributable to owners of the parent was ¥2,306 million. Revenue and profit declined, while the increase in foreign exchange gains lifted ordinary income.
  23. FY2020-Q1Updated first-quarter resultsAnnual report

    「As a result, net sales for the cumulative first quarter were ¥4,345 million, down 9.5% year on year, operating income was ¥1,401 million, down 11.8%, ordinary income was ¥1,578 million, down 5.3% despite an increase in foreign exchange gains from the prior-year period, and quarterly net income attributable to owners of the parent was ¥1,050 million, down 66.0% due to a decrease in gains on sales of investment securities and the recognition of a loss from the Vietnam plant fire.」

    FY2020-Q1 saw declines in both revenue and profit, with net sales down 9.5%, operating income down 11.8%, ordinary income down 5.3% and quarterly net income attributable to owners of the parent down 66.0%. Net income was affected by a decrease in gains on sales of investment securities and the loss from the Vietnam plant fire.
  24. FY2019Updated full-year resultsAnnual report

    「Net sales for the fiscal year were ¥18,327 million, down 8.8% year on year, operating income was ¥5,865 million, up 15.5% due to an improved cost-of-sales ratio associated with establishing increased production capacity at the second Phu Yen plant and a decrease in selling, general and administrative expenses following the transfer of shares in Schütz Dental GmbH, ordinary income was ¥5,688 million, up 9.0% despite an increase in foreign exchange losses from the prior-year period, and net income attributable to owners of the parent was ¥6,101 million, up 61.8% due to the recognition of a ¥2,750 million gain on sales of investment securities from the sale of shares in line with the Corporate Governance Code’s policy of reducing cross-shareholdings.」

    Full-year revenue declined, while operating income, ordinary income and net income increased due to increased production and an improved cost ratio at the second Phu Yen plant, lower SG&A expenses following the transfer of Schütz Dental GmbH and other factors.
  25. FY2019-Q3Third-quarter results disclosedAnnual report

    「Net sales for the cumulative third quarter were ¥13,778 million, down 7.9% year on year, operating income was ¥4,502 million, up 17.5% due to an improved cost-of-sales ratio associated with establishing increased production capacity at the second Phu Yen plant and a decrease in selling, general and administrative expenses following the transfer of shares in Schütz Dental GmbH, ordinary income was ¥4,464 million, up 15.3% despite an increase in foreign exchange losses from the prior-year period, and quarterly net income attributable to owners of the parent was ¥5,105 million, up 87.7% due to the recognition of a ¥2,749 million gain on sales of investment securities from the sale of shares in line with the Corporate Governance Code’s policy of reducing cross-shareholdings.」

    Cumulative third-quarter net sales declined 7.9%, while operating income increased 17.5%, ordinary income increased 15.3% and quarterly net income attributable to owners of the parent increased 87.7%.
  26. FY2019-Q2Second-quarter results disclosedAnnual report

    「As a result, net sales for the cumulative second quarter were ¥9,088 million, down 5.9% year on year, operating income was ¥2,906 million, up 21.4% due to an improved cost-of-sales ratio associated with establishing increased production capacity at the second Phu Yen plant and a decrease in selling, general and administrative expenses following the transfer of shares in Schütz Dental GmbH, ordinary income was ¥2,921 million, up 20.6% despite an increase in foreign exchange losses from the prior-year period, and quarterly net income attributable to owners of the parent was ¥4,034 million, up 140.3% due to the recognition of a ¥2,749 million gain on sales of investment securities from the sale of shares in line with the Corporate Governance Code’s policy of reducing cross-shareholdings.」

    Cumulative second-quarter revenue declined, while operating income increased 21.4% due to the improved cost ratio at the second Phu Yen plant and lower SG&A expenses following the transfer of Schütz Dental GmbH, and net income increased 140.3% due to gains on sales of investment securities.
  27. FY2019-Q1First-quarter results disclosedAnnual report

    「As a result, net sales for the cumulative first quarter were ¥4,801 million, up 2.0% year on year, operating income was ¥1,589 million, up 40.1% due mainly to an improvement in the cost-of-sales ratio associated with establishing increased production capacity at the second Phu Yen plant, ordinary income was ¥1,667 million, up 35.5% despite a decrease in foreign exchange gains from the prior-year period, and quarterly net income attributable to owners of the parent was ¥3,086 million, up 266.0% due to the recognition of a gain on sales of investment securities.」

    FY2019-Q1 results disclosed net sales of ¥4,801 million, operating income of ¥1,589 million, ordinary income of ¥1,667 million and quarterly net income attributable to owners of the parent of ¥3,086 million, representing increases in revenue and profit. Operating income was affected by the improvement in the cost-of-sales ratio associated with establishing increased production capacity at the second Phu Yen plant, while net income was affected by a gain on sales of investment securities.
  28. FY2018Full-year results disclosedAnnual report

    「As a result, net sales for the fiscal year were ¥20,102 million, up 17.1% year on year, operating income was ¥5,080 million, up 19.2%, ordinary income was ¥5,221 million, up 12.9%, as the increase in operating income more than offset the decrease in foreign exchange gains from the previous fiscal year, and net income attributable to owners of the parent was ¥3,770 million, up 13.7%, despite the recognition of a loss on the sale of shares in an affiliate and goodwill impairment loss in connection with the transfer of shares in Schütz Dental GmbH, due in part to an increase in gains on sales of investment securities.」

    Disclosed full-year net sales, operating income, ordinary income and net income attributable to owners of the parent, and explained the effects of the decrease in foreign exchange gains, the loss on the transfer of Schütz shares and goodwill impairment loss.
  29. FY2018-Q3Third-quarter results disclosedAnnual report

    「As a result, net sales for the cumulative third quarter were ¥14,966 million, up 20.8% year on year, operating income was ¥3,831 million, up 21.3%, ordinary income was ¥3,871 million, up 12.8% due to a decrease in foreign exchange gains, and quarterly net income attributable to owners of the parent was ¥2,719 million, up 10.7%.」

    Disclosed cumulative third-quarter net sales, operating income, ordinary income and quarterly net income attributable to owners of the parent, together with year-on-year comparisons. Revenue and operating income increased, while the decrease in foreign exchange gains was cited as a factor affecting ordinary income.
  30. FY2018-Q2Second-quarter results disclosedAnnual report

    「As a result, net sales for the cumulative second quarter were ¥9,663 million, up 17.8% year on year, operating income was ¥2,393 million, up 10.1%, ordinary income was ¥2,421 million, up 1.3% despite a decrease in foreign exchange gains, and quarterly net income attributable to owners of the parent was ¥1,678 million, down 1.0% due to an increase in taxes paid.」

    Cumulative second-quarter revenue and operating income increased, ordinary income rose despite a decrease in foreign exchange gains, and quarterly net income attributable to owners of the parent declined.
  31. FY2018-Q1First-quarter results disclosedAnnual report

    「As a result, net sales for the cumulative first quarter were ¥4,708 million, up 16.7% year on year, operating income was ¥1,134 million, up 7.6%, ordinary income was ¥1,231 million, down 1.2% due to a decrease in foreign exchange gains, and quarterly net income attributable to owners of the parent was ¥843 million, up 0.1%.」

    First-quarter revenue and operating income increased, while ordinary income declined due to a decrease in foreign exchange gains and quarterly net income attributable to owners of the parent edged up.
  32. FY2017Full-year results disclosedAnnual report

    「As a result, net sales for the fiscal year were ¥17,167 million, up 3.7% year on year, operating income was ¥4,261 million, up 0.4%, ordinary income was ¥4,624 million, up 14.1% due to an increase in foreign exchange gains, and net income attributable to owners of the parent was ¥3,315 million, up 10.3%.」

    Disclosed full-year net sales, operating income, ordinary income and net income attributable to owners of the parent. While revenue increased and operating income edged up, ordinary income and net income increased more substantially due to foreign exchange gains.
  33. FY2017-Q3Third-quarter results disclosedAnnual report

    「As a result, net sales for the cumulative third quarter were ¥12,392 million, up 2.1% year on year, operating income was ¥3,158 million, down 2.7%, ordinary income was ¥3,432 million, up 8.3% due to an increase in foreign exchange gains, and quarterly net income attributable to owners of the parent was ¥2,457 million, up 6.8%.」

    Disclosed that cumulative third-quarter net sales increased while operating income declined, and ordinary income and quarterly net income attributable to owners of the parent increased against the backdrop of foreign exchange gains.
  34. FY2017-Q2Second-quarter results disclosedAnnual report

    「As a result, net sales for the cumulative second quarter were ¥8,205 million, up 4.9% year on year, operating income was ¥2,174 million, up 20.6%, ordinary income was ¥2,390 million, up 38.6%, and quarterly net income attributable to owners of the parent was ¥1,695 million, up 37.4%.」

    Disclosed net sales, operating income, ordinary income and quarterly net income attributable to owners of the parent for the cumulative second quarter, together with year-on-year comparisons. By segment, profit in Surgical, Eyeless Needles and Dental each exceeded the prior-year period.
  35. FY2017-Q1First-quarter results disclosedAnnual report

    「As a result, net sales for the cumulative first quarter were ¥4,036 million, up 0.8% year on year, operating income was ¥1,054 million, up 16.4%, ordinary income was ¥1,245 million, up 43.2% due to an increase in foreign exchange gains, and quarterly net income attributable to owners of the parent was ¥842 million, up 49.4%.」

    Following the full-year results, disclosed first-quarter net sales, operating income, ordinary income and quarterly net income attributable to owners of the parent.
  36. FY2016Full-year results disclosedAnnual report

    「Net sales for the fiscal year were ¥16,555 million, up 19.7% year on year, operating income was ¥4,245 million, up 1.6%, ordinary income was ¥4,055 million, down 6.7% due to an increase in foreign exchange losses, and net income attributable to owners of the parent was ¥3,005 million, up 2.5% due to a decrease in corporate, inhabitant and enterprise taxes.」

    Disclosed full-year net sales, operating income, ordinary income and net income based on the cumulative quarterly figures, and indicated the factors behind the changes in revenue and profit.
  37. FY2016-Q3First statedAnnual report

    「As a result, net sales for the cumulative third quarter were ¥12,132 million, up 28.0% year on year, operating income was ¥3,244 million, up 0.4%, ordinary income was ¥3,170 million, down 5.5% due to an increase in foreign exchange losses, and net income attributable to owners of the parent was ¥2,299 million, up 5.1% due to a decrease in corporate, inhabitant and enterprise taxes.」

    Net sales increased 28.0% year on year, operating income increased 0.4%, ordinary income decreased 5.5%, and quarterly net income attributable to owners of the parent increased 5.1%.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Mani's next results are scheduled for 2026-10-15. Read the earnings preview It last moved in the Earnings of 2026-07-15: "Cited as achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.